KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC

Lobbying for MAYNE PHARMA COMMERCIAL LLC · Pharmaceutical company

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $30,000.00 income · posted Jan 15, 2026

Lobbying activity 1

Health Issues

Issues related to coverage of pharmaceutical products

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.